Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (151-160 of 740) with videos related to

Pageof 74
Sort By:
International Journal of Antimicrobial Agents|October 12, 2014
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection siteFederico Pea, Piergiorgio Cojutti, Maria Merelli, et al.
BMC Infectious Diseases|August 8, 2012
Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?Anna Marchese, Susanna Esposito, Ramona Barbieri, et al.
European Journal of Clinical Pharmacology|August 9, 2015
Linezolid underexposure in a patient co-treated with venlafaxinePiergiorgio Cojutti, Massimo Crapis, Matteo Bassetti, et al.
Future Microbiology|December 17, 2008
Drug treatment for multidrug-resistant Acinetobacter baumannii infectionsMatteo Bassetti, Elda Righi, Silvano Esposito, et al.
Current Medicinal Chemistry|February 10, 2009
Current status of newer carbapenemsMatteo Bassetti, Laura Nicolini, Silvano Esposito, et al.
Current Opinion in Infectious Diseases|February 19, 2020
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infectionsMatteo Bassetti, Laura Magnasco, Filippo Del Puente, et al.
Expert Review of Anti-Infective Therapy|December 21, 2012
Epidemiology, diagnosis and treatment of Clostridium difficile infectionMatteo Bassetti, Giovanni Villa, Davide Pecori, et al.
Expert Opinion on Investigational Drugs|April 2, 2009
The role of telavancin in the treatment of MRSA infections in hospitalMatteo Bassetti, Malgorzata Mikulska, Elda Righi, et al.
Annals of Intensive Care|April 20, 2016
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patientMatteo Bassetti, Charles-Edouard Luyt, David P Nicolau, et al.
Current Opinion in Infectious Diseases|January 17, 2018
New antibiotics for ventilator-associated pneumoniaMatteo Bassetti, Antionio Vena, Nadia Castaldo, et al.
Pageof 74

Showing results (151-160 of 740) with videos related to

Sort By:
Pageof 74
International Journal of Antimicrobial Agents|October 12, 2014
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection siteFederico Pea, Piergiorgio Cojutti, Maria Merelli, et al.
BMC Infectious Diseases|August 8, 2012
Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?Anna Marchese, Susanna Esposito, Ramona Barbieri, et al.
European Journal of Clinical Pharmacology|August 9, 2015
Linezolid underexposure in a patient co-treated with venlafaxinePiergiorgio Cojutti, Massimo Crapis, Matteo Bassetti, et al.
Future Microbiology|December 17, 2008
Drug treatment for multidrug-resistant Acinetobacter baumannii infectionsMatteo Bassetti, Elda Righi, Silvano Esposito, et al.
Current Medicinal Chemistry|February 10, 2009
Current status of newer carbapenemsMatteo Bassetti, Laura Nicolini, Silvano Esposito, et al.
Current Opinion in Infectious Diseases|February 19, 2020
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infectionsMatteo Bassetti, Laura Magnasco, Filippo Del Puente, et al.
Expert Review of Anti-Infective Therapy|December 21, 2012
Epidemiology, diagnosis and treatment of Clostridium difficile infectionMatteo Bassetti, Giovanni Villa, Davide Pecori, et al.
Expert Opinion on Investigational Drugs|April 2, 2009
The role of telavancin in the treatment of MRSA infections in hospitalMatteo Bassetti, Malgorzata Mikulska, Elda Righi, et al.
Annals of Intensive Care|April 20, 2016
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patientMatteo Bassetti, Charles-Edouard Luyt, David P Nicolau, et al.
Current Opinion in Infectious Diseases|January 17, 2018
New antibiotics for ventilator-associated pneumoniaMatteo Bassetti, Antionio Vena, Nadia Castaldo, et al.
Pageof 74